MCL1 and B-cell chronic lymphocytic leukemia: Several cellular regulatory processes, such as the modulation of lymphoid transcription and the AMPK/PKA axis, cellular energy metabolism, and overexpression of MCL1, contribute to venetoclax resistance in chronic lymphocytic leukemia [57].